Clinical Trial Update: Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating stereotactic body radiation therapy for unresectable locally recurrent rectal cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Locally Recurrent Rectal Cancer
• Rectal Cancer

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Unresectable Locally Recurrent Rectal Cancer | Phase 2 | Status: RECRUITING